The PediQUEST Response Intervention Study

NACompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 14, 2022

Study Completion Date

September 14, 2022

Conditions
Advanced Cancer
Interventions
OTHER

PediQUEST Response

PediQUEST Response consists of regular feedback of electronic patient reported outcomes (child symptoms and quality of life) to providers and families coupled with involvement of the palliative care team, who will meet with families and providers within three weeks of randomization and follow-up at least monthly as deemed necessary based on PediQUEST feedback reports and other clinical indications.

OTHER

Usual Cancer Care

Patients assigned to the usual cancer care arm, will receive the standard care provided by participating sites + be required to complete PediQUEST surveys (but no reports will be generated).

Trial Locations (6)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

77030

Texas Children's Hospital, Houston

02215

Boston Children's Hospital, Boston

Dana Farber Cancer Institute, Boston

19104-4318

The Children's Hospital of Philadelphia, Philadelphia

98145-5005

Seattle Children's Research Institute, Seattle

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

Seattle Children's Hospital

OTHER

collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

Children's Hospitals and Clinics of Minnesota

OTHER

collaborator

Nationwide Children's Hospital

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Deakin University

OTHER

collaborator

Boston Children's Hospital

OTHER

collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Joanne Wolfe, MD, MPH

OTHER

NCT03408314 - The PediQUEST Response Intervention Study | Biotech Hunter | Biotech Hunter